SEC Form 4 · accession 0001225208-18-002314

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP & President, Rhythm Mgmt

Period of report

Feb 7, 2018

Accepted (ET)

Feb 8, 2018 · 4:14 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Feb 7, 2018	M	85,227	$12.52	A	237,152	D
Common Stock^F3,F2	Feb 7, 2018	S	85,227	$26.4784	D	151,925	D
Common Stock^F4	holding	—	—		—	77,323	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F5	$12.52	Feb 7, 2018	M	85,227	D	—	Feb 12, 2018	Common Stock	85,227	0	D

F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.39 to $26.57, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F4Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F5Grant to the reporting person of an option to purchase 85,227 shares of common stock vesting in four annual increments beginning on February 12, 2009, the first anniversary of the grant.